Facebook Pixel India cuts China bulk-drug reliance | Mint Hyderabad - newspaper - Bu hikayeyi Magzter.com'da okuyun

Denemek ALTIN - Özgür

India cuts China bulk-drug reliance

Mint Hyderabad

|

March 17, 2025

Bulk drugs accounted for 63% of the total pharmaceutical imports in the country during FY 2018-19

- Priyanka Sharma

Indian companies have started manufacturing important bulk drugs or active pharmaceutical ingredients (APIs) under the government's production linked incentive (PLI) scheme.

The production of Penicillin G and Clavulanic Acid began in October last year. Other APIs already in production include Atorvastatin, Sulfadiazine, Telmisartan, Olmesartan, Para Amino Phenol (raw material for paracetamol) and Oxcarbazepine.

The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.

These bulk drugs are largely used as antibiotics and to manage non-communicable diseases such as cardiovascular diseases, chronic respiratory diseases, and diabetes.

Mint Hyderabad'den DAHA FAZLA HİKAYE

Mint Hyderabad

How low-hanging fruit could give India outsized gains

The Iran conflict has made two things clear: One, a new wave of globalization is coming, like it or not, from which further such shocks can’t be ruled out; and two, dependable dollar inflows from export earnings need to grow handsomely.

time to read

3 mins

June 26, 2026

Mint Hyderabad

Careful planning can help India take on its inflation challenges

Rising pressures amid an El Niño-hit monsoon make a case for pre-emptive government measures

time to read

3 mins

June 26, 2026

Mint Hyderabad

Air Suvidha back amid Ebola scare

An upgraded version of the air passenger health self-declaration portal Air Suvidha has been launched to enhance public health surveillance amid the Ebola outbreak in certain parts of Africa.

time to read

1 min

June 26, 2026

Mint Hyderabad

Mint Hyderabad

A pick of films, art and food

A Mint guide to what's happening in and around your city

time to read

1 min

June 26, 2026

Mint Hyderabad

Mint Hyderabad

Traceability rules cover vaccines, cancer drugs now

The Union health ministry expanded mandatory track-and-trace requirements to cover all vaccines, antibiotics, cancer drugs and narcotic and psychotropic substances, widening an anti-counterfeiting system that previously applied only to India’s 300 top-selling drug brands.

time to read

1 min

June 26, 2026

Mint Hyderabad

Mint Hyderabad

Regulator cracks down on smuggled, unapproved drugs

DGCI order follows a rise in illegal entry and sale of fake drugs from neighbouring countries

time to read

2 mins

June 26, 2026

Mint Hyderabad

As China relations thaw, India set to okay Geely-backed deal

India is set to approve a roughly $370 million investment from Horse Powertrain Ltd, a hybrid-engine venture backed by China’s Zhejiang Geely Holding Group Co., that would mark one of the biggest manufacturing investments from a Chinese-linked company in years.

time to read

1 mins

June 26, 2026

Mint Hyderabad

Mint Hyderabad

How a crypto exchange became a hub for illicit Iranian cash

Earlier this year, crypto sleuths found an alarming series of transactions tied to two digital wallets controlled by the Central Bank of Iran.

time to read

1 mins

June 26, 2026

Mint Hyderabad

India Inc should make queer inclusion an imperative

I grew up in Calcutta in the 2000s. Raised by a single mother, our home was full of activity. My mother carried extraordinary strength into the corporate world.

time to read

3 mins

June 26, 2026

Mint Hyderabad

Mint Hyderabad

Vedanta's Navin Agarwal bets big on RE magnets

10,000 tonnes in phases, Shukla said. Agarwal's ₹1,250 crore investment will be for the first phase, he added.

time to read

1 mins

June 26, 2026

Listen

Translate

Share

-
+

Change font size